SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-23-007436
Filing Date
2023-03-07
Accepted
2023-03-07 20:51:50
Documents
1
Period of Report
2023-03-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7688
  Complete submission text file 0000899243-23-007436.txt   9817
Mailing Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024
Business Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024 (858) 945-2393
Ventyx Biosciences, Inc. (Issuer) CIK: 0001851194 (see all company filings)

IRS No.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 500 WEST PUTNAM AVE SUITE 400 GREENWICH CT 06830
Business Address 500 WEST PUTNAM AVE SUITE 400 GREENWICH CT 06830 2126885100
NSV Partners III GP LLC (Reporting) CIK: 0001889601 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40928 | Film No.: 23714652

Mailing Address 500 WEST PUTNAM AVE SUITE 400 GREENWICH CT 06830
Business Address 500 WEST PUTNAM AVE SUITE 400 GREENWICH CT 06830 2126885100
NSV Partners III LP (Reporting) CIK: 0001890004 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40928 | Film No.: 23714653